Received Oct 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | — | — |
Headache; Flu-like symptoms; felt terrible; This non-serious case was reported by a consumer via call center representative and described the occurrence of headache in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced headache (Verbatim: Headache), influenza-like symptoms (Verbatim: Flu-like symptoms) and feels awful (Verbatim: felt terrible). The outcome of the headache, influenza-like symptoms and feels awful were resolved. It was unknown if the reporter considered the headache, influenza-like symptoms and feels awful to be related to Shingrix. It was unknown if the company considered the headache, influenza-like symptoms and feels awful to be related to Shingrix. Additional Information: GSK Receipt Date:19-SEP-2025 Reporter reported that the patient had a bad reaction to the Shingrix shot 2 which included flu-like symptoms and headache. Patient felt terrible for a day or two. Patient felt so miserable that was concerned about how she was going to get to the hospital if she needed to go (as she did not think she would be able to drive due to how terrible she felt). These events resolved.